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Introducing the GEV Activation Function for
Highly Unbalanced Data to Develop COVID-19
Diagnostic Models
Joshua Bridge, Yanda Meng, Yitian Zhao, Yong Du, Mingfeng Zhao, Renrong Sun, and Yalin Zheng
Abstract— Fast and accurate diagnosis is essential for
the efficient and effective control of the COVID-19 pandemic
that is currently disrupting the whole world. Despite the
prevalence of the COVID-19 outbreak, relatively few diag-
nostic images are openly available to develop automatic
diagnosis algorithms. Traditional deep learning methods
often struggle when data is highly unbalanced with many
cases in one class and only a few cases in another; new
methods must be developed to overcome this challenge.
We propose a novel activation function based on the gener-
alized extreme value (GEV) distribution from extreme value
theory, which improves performance over the traditional
sigmoid activation function when one class significantly
outweighs the other. We demonstrate the proposed activa-
tion function on a publicly available dataset and externally
validate on a dataset consisting of 1,909 healthy chest
X-rays and 84 COVID-19 X-rays. The proposed method
achieves an improved area under the receiver operating
characteristic (DeLong’s p-value <0.05) compared to the
sigmoid activation. Our method is also demonstrated on
a dataset of healthy and pneumonia vs. COVID-19 X-rays
and a set of computerized tomography images, achieving
improved sensitivity. The proposed GEV activation function
significantly improves upon the previously used sigmoid
activation for binary classification. This new paradigm is
expected to play a significant role in the fight against
COVID-19 and other diseases, with relatively few training
cases available.
Index Terms— Artificial intelligence, Computer-aided de-
tection and diagnosis, COVID-19, Extreme value theory,
Lung, X-ray and computed tomography
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COVID-19 is an acute respiratory syndrome with over 6.4million cases as of 4 June 2020, with the number of
cases rapidly increasing, and over 382,000 deaths reported
worldwide [1]. Fast and accurate diagnosis is essential for
the efficient and effective control of this pandemic. Reverse-
transcription polymerase chain reaction (RT-PCR) is the cur-
rent standard test for the COVID-19. RT-PCR has been found
to have a variable sensitivity with a low value of 71% when
compared to computerized tomography (CT) with a sensitivity
of 98% (p<0.01) [2], leading to a significant number of false
negatives. Currently, there are no other laboratory tests able to
provide timely results with such high sensitivity.
The World Health Organization has outlined several sce-
narios in which laboratory testing may not be sufficient and
chest imaging is needed [3]. Medical imaging is quickly
becoming vital in the diagnosis of COVID-19 as imaging is
faster, cheaper, and more readily available compared to RT-
PCR. CT based COVID-19 diagnosis is reported to have a
higher sensitivity (80-90%) when compared to laboratory tests
at the expense of specificity (60-70%) [4]. Chest X-ray is a
cheaper alternative to CT with a faster image acquisition time;
X-Ray equipment is also easier to sanitize compared to CT
machines. Chest X-ray is of most use in low income, low
resource settings, such as developing countries or community
screening programs. A study into the radiological features of
COVID-19 [5], reported that the most significant feature is
ground-glass opacification (GGO), sometimes accompanied by
consolidation in more severe forms [6]. In some cases, these
features were observable on CT but not on X-ray imaging. The
authors concluded that CT might be more sensitive to these
features than X-ray.
Given that COVID-19 is a relatively new condition, there
are currently no experienced COVID-19 radiologists compared
to other established conditions, and there is little time for
training. The disease affects a large number of patients within
a short period of time, and as a result, experts are overladen
with the number of cases requiring imaging and diagnosis;
this is likely to become worse as countries look to increase
testing. With such a rapid rate of infection, a new, fast,
and accurate method of COVID-19 diagnosis is required.
Although some countries, such as China, have been successful
in controlling the spread of the virus, it is feared that, as
restrictions are relaxed, the virus will become established
in populations; therefore, a robust and effective strategy to
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diagnose COVID-19 must be found. Moreover, imaging may
play an essential role in assessing the disease response to
treatment, further facilitating the urgently needed development
of effective treatments.
The automated diagnosis of COVID-19 is an active research
area as surveyed by Shi et al. [7] and Wynants et al. [8]. De-
spite the high prevalence of the virus, relatively few COVID-
19 images are available to build a deep learning automatic
diagnosis model, compared to the availability of healthy or
non-COVID-19 images. If all available images are used,
then COVID-19 cases will be under-represented, potentially
resulting in many false negatives. This echoes the common
issue of unbalanced data in medical image analysis. Previous
methods to combat this problem primarily rely on resampling
the under-represented data or reweighting the loss function [9];
this can lead to overfitting or can significantly increase training
time. Here, we propose a novel activation function based on
the generalized extreme value (GEV) distribution in extreme
value theory [10] to address this fundamental problem. The
proposed GEV activation function is better able to model the
tail of unbalanced data, where one class has relatively few
cases when compared to the other.
We first show the benefit of our proposed activation function
over sigmoid in a balanced dataset of X-ray images. We
report performance at different level of imbalance and show
improved results over using sigmoid and using oversampling
strategy with the sigmoid activation. We then demonstrate
the GEV activation function by developing three prediction
models to diagnose COVID-19. The first model aims to
diagnose COVID-19 from a set consisting of healthy vs.
COVID-19 X-ray images; these images may be observed in a
screening program. The second model diagnoses COVID-19
from a set of COVID-19 vs. healthy and pneumonia X-ray
images. The final model classifies CT images as COVID-19
or non-COVID-19, which may have other diseases present.
The GEV activation function can achieve excellent per-
formance with relatively few positive training images. By
reducing the number of COVID-19 images needed for training,
we can use more images in the testing to better assess the
generalizability of the model. The models developed here are
to demonstrate the strength of the proposed activation function,
and we believe that our proposed GEV based model will form
the basis for further development towards real-world clinic use
after proper clinical evaluation.
A. Contributions
Our main contributions are in both methodology and ap-
plications, for deep learning and medical image analysis, we
propose an activation function based on the GEV distribution,
which aims to model the distribution of unbalanced data better.
To the best of our knowledge, this is the first time such an
activation function has been utilized within deep learning.
We demonstrate the added benefit of the GEV activation by
comparing it to the classic sigmoid activation, with improved
sensitivity. We show that the proposed activation reduces the
number of images required in training. The GEV function
can be used with any convolutional neural network (CNN)
and alongside other unbalanced data methods, such as class
weights. In terms of applications, we have applied the new
activation function to the diagnosis of COVID-19 using X-
Rays and CT images and made some groundbreaking work for
the future development of fast and accurate diagnosis solutions
of COVID-19.
II. RELATED WORK
In this section, we provide a concise and thorough overview
of the related work in the diagnosis of COVID-19 using X-
ray and CT images, attempts to overcome the unbalanced data
problem, and general uses of extreme value theory.
Deep learning-based methods have previously been used to
diagnose a variety of diseases from medical images accurately,
often outperforming human graders [11]. More recently, deep
learning has been applied to medical images to detect COVID-
19 [7]. For brevity, we do not consider papers focusing solely
on COVID-19 segmentation; readers interested in segmenta-
tion may wish to read a recent review of AI in COVID-19
[7].
A. X-Ray Diagnosis
Wang et al. [12] developed a custom CNN with a residual
architecture, to classify images as COVID-19, pneumonia, or
healthy. The model was trained on publicly available images
from two datasets [13], [14]. With only 10 COVID-19 images
in the testing dataset, the model attained a sensitivity of 0.80
and a specificity of 0.995. This work suggests that future
models need to improve sensitivity to reduce the number of
false negatives.
A Bayesian convolutional neural network (BCNN) with
drop weights, based on ResNet-50 V2 [15], was proposed by
Ghoshal et al. [16]. Data consisted of four classes, normal,
bacterial pneumonia, non-COVID-19 viral pneumonia, and
COVID-19. A total of 14 COVID-19 images were used in
the testing dataset. In both CNNs and BCNNs with a range
of drop weights, two of the COVID-19 cases were wrongly
classified. For COVID-19 diagnosis, their best model attained
a sensitivity of 0.857 and a specificity of 0.995. Various
saliency maps were used to reduce the black-box nature of
deep learning; however, the maps appeared to highlight some
wrong areas such as the collarbone, and this was not explained
or investigated within the paper. The study concluded that by
estimating uncertainty within predictions, model performance
can be improved.
Narin et al. [17] obtained 50 healthy and 50 COVID-
19 patients and used three different pretrained deep learning
networks to diagnose COVID-19. Using ten images from each
class in a testing set, they obtained perfect performance in
using Inception V3 [18] and ResNet-50 [19], with Inception-
ResNet V2 [20] misclassifying one of the healthy images as
COVID-19. They suggested that transfer learning can be used
to build deep learning models for COVID-19 diagnosis. An 18-
layer residual CNN pretrained on ImageNet [21] was proposed
by Zhang et al. [22]. The CNN was followed by fully-
connected layers and a sigmoid activation for classification. A
separate anomaly detection mechanism was also added to the
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end of the CNN. Sensitivity and specificity were reported at
different thresholds, the model achieves a sensitivity of 0.72 at
0.98 specificity and a sensitivity of 0.966 at 0.707 specificity,
in two-fold cross-validation of 100 images from 70 patients.
In summary, these models appear to perform very well;
however, increasing the sensitivity of models is a priority due
to the risk associated with missing a COVID-19 diagnosis.
B. CT Diagnosis
There have been more models developed using CT to
diagnose COVID-19, many are reviewed in [8] and [7]
Chen et al. [23] used a UNet++ [24] based approach for the
detection of COVID-19 lesions and then for the diagnosis of
COVID-19. The model was trained on expert annotated CT
slices to extract COVID-19 areas. They concluded that their
algorithm has comparable performance to expert radiologists,
with a reported sensitivity of 1.0 on the patient level, with
16 suspected pneumonia and 11 COVID-19 patients. Shan et
al. [25] used a similar method with a different network to
segment and quantify COVID-19, achieving a dice score of
0.916, with 300 COVID-19 patients. The authors proposed
that their method could be used to analyze the progression of
the disease.
Gozes et al. [26] combined commercial software and deep
learning to segment and quantify COVID-19, with a reported
area under the receiver operating characteristic (AUC) of
0.996. Li et al. [27] used a ResNet-50 network for each slice in
a CT image, with shared weights. Max pooling then combined
the slices to provide a single feature vector, which was then
classified. The method achieved an AUC of 0.96, with 285
healthy and 68 COVID-19 patients. A patch-based method
with a support vector machine was proposed by Barstugan
et al. [28]; this achieved a specificity of 1.0 and a sensitivity
of 0.93 using a cross-validation of 53 patients.
Shi et al. [29] segmented scans to extract infection and
lung fields, an infection size aware random forest classifier
then classified images according to infection size. The method
attained an overall AUC of 0.94, with 1,027 healthy and
1,658 COVID-19 patients using 5-fold cross validation. Jin
et al. [30] first segmented lesions using a 3D neural network,
before classifying those lesions as COVID-19 or not, with a
2D ResNet network. Data from two hospitals were used and
this method achieved an AUC of 0.99 on 128 healthy and
154 COVID-19 patients. Jin et al. [31] used a segmentation
network (Deeplab v1, [32]) and a ResNet152 classification
network for the classification of CT slices, GradCAMs [33]
were then produced to highlight the diseased area. This
network was trained on local and public datasets, achieving
an AUC of 0.98 on 1,072 healthy and 183 COVID-19 pa-
tients. Xu et al. [34] proposed using a deep learning model
to segment out the candidate infection regions. Patches of
infected regions, with the distances from the edge of the lung,
were input to a ResNet-18 network for classification into three
groups: COVID-19, Influenza-A, and healthy patients. The
model achieves an overall accuracy of 0.867 on 30 COVID-19
patients and 60 other patients.
Wang et al. [35] have applied an inception network for
the diagnosis of COVID-19 using an in-house dataset. They
reported a total accuracy of 89.5% with a specificity of 0.88
and a sensitivity of 0.87 in the internal validation, and a total
accuracy of 0.793 with a specificity of 0.83 and a sensitivity
of 0.67 in the external validation set. The external validation
set consisted of 100 healthy patients, 100 pneumonia patients,
and 10 COVID-19 patients. Song et al. [36] proposed using
ResNet-50, and a feature pyramid network (FPN) combined
with an attention module and experimented on their in-
house dataset. An AUC of 0.99 and a sensitivity of 0.93
for COVID19 and healthy images were reported, on a set
of 24 healthy and 27 COVID-19 patients. In a dataset of 30
pneumonia 27 COVID-19 patients, their method attained an
AUC of 0.95 and a sensitivity of 0.96 for COVID and bacteria
pneumonia-infected patients.
Tang et al. [37] used a random forest (RF) model to
assess the severity of COVID-19 based on quantitative features
derived from a deep learning model. With three-fold cross-
validation on 176 patients the method attained an overall
accuracy of 0.875. A weakly supervised method was proposed
by Zheng et al. [38]. Their method automatically generated
segmentation masks. The CT image and mask are fed into a
3D CNN for classification. This method attained an AUC of
0.959.
In summary, similar to the studies using X-ray imaging,
most studies use a small number of COVID-19 images from
different resources without standardized protocols. It seems
that they are just applications of existing AI tools to a new
problem, and thus novelty in AI and clinical usefulness are
limited. The high data heterogeneity among the studies makes
it difficult to compare with. Although all models achieved
excellent performance, Wynants et al. [8] found that the risk
of bias high in all the eight studies that they have reviewed,
according to PROBAST [39].
Overall models for COVID-19 diagnosis, using X-ray or CT
images, attain excellent performance; however, some models
only use as few as 10 COVID-19 images within the testing
set, and few models use external validation primarily due
to the issue of data availability. Therefore they may not
necessarily be generalizable to other cases. A method that
is more data-efficient, attaining high performance with fewer
training images is needed; this would allow more images of
the rare class to be used in the testing data. The aim of our
work is not necessarily to beat these previous models but to
provide a method which may improve the previous models.
C. Unbalanced Data
When a dataset has only a few classes containing the
majority of the data and many classes that only occur a few
times, the data distribution becomes long-tailed. It has been
observed that the classes with more samples have a greater
effect on the learned features [40]. The most frequent classes
become much easier to model, and the tail of the distribution,
consisting of rarer classes, is not adequately modeled [41].
This issue exists in both binary and multiclass problems and
remains a major challenge in data science.
There are many published methods aimed at addressing the
issue of unbalanced data by better modeling the tail of the data
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distribution. Several papers have proposed reweighting the loss
function [42] or oversampling under-represented classes. Other
methods include utilizing representation learning [41], learning
features by clustering classes into visually similar groups [40],
and introducing a loss function to increase the within-subject
variation [22].
More recently, Cui et al. [9] proposed a new loss function
that exploits the information overlap within the data. They
argue that although more data will increase the information
available, the marginal benefit will decrease with each new
sample due to information within the data overlapping. The
authors provide a theoretical framework for quantifying the
data overlap so that the theoretical effective number of sam-
ples. The effective number of samples allows samples from the
training set to rebalance the data slightly; however, this does
not guarantee that the data will then be sufficiently balanced.
D. Extreme Value Distributions
Deep learning classification networks often consist of a
CNN followed by classification layers comprised of a fully
connected (FC) layer and an activation function, usually sig-
moid for binary classification and softmax for multiclass clas-
sification. When the sigmoid activation function is used, then
the classification layers become analogous to a generalized
linear model with logistic link function, also called logistic
regression. Logistic regression uses the sigmoid function as a
link function and assumes that the errors follow the logistic
distribution; however, this assumption is not valid in highly
skewed or unbalanced data.
In highly unbalanced data, it is vital to model the tail and
skewness of the distribution appropriately, to avoid introducing
bias. A simulation study by Czado and Santner [43] found that
a highly mispecified link function greatly increases bias in both
the parameter estimates and the predicted probability. A highly
skewed distribution such as the GEV distribution can be used
to properly describe the distribution, ensuring that bias within
the model is reduced.
In traditional statistics for problems such as finance,
weather, or epilepsy [44], [45], link functions based on ex-
treme value distributions [10] have been proposed for when
data is highly unbalanced. Extreme value distributions assume
that the errors follow a highly skewed distribution, such as
those observed when data has some rare classes.
Extreme value theory has previously been used in deep
learning to infer labels from intermediate CNN features from
a bag of 3D image volumes, in multiple-instance learning
[46]. Our work differs significantly by using the generalized
extreme value distribution to create a new activation function,
which improves classification, in particular sensitivity, when
one class has significantly fewer cases.
III. METHODS
We first describe the general network in which the proposed
activation function may be used. We then describe the pro-
posed activation function and its implementation. An overview















Fig. 1. Overview of the general framework. The dataset is highly
unbalanced, with one class significantly outweighing the other. A CNN
is used to extract features from the images. A fully connected layer then
reduces the features to a single value using a linear combination. The
GEV activation function converts that value to a probability.
A. CNN
The proposed activation function may be added to any
neural network, including pretrained networks such as ResNet
[15], [19] or more novel networks such as COVID-NET [12].
Here, we begin with a pretrained CNN, namely Inception V3
[18]. Inception V3 is a variation of the original inception
network with improvements in accuracy and a reduction in
computational complexity. Inception V3 is commonly used in
classification problems, due to its high generalizability. Incep-
tion V3 attains high accuracy while maintaining reasonable
computational efficiency through its use of batch normalization
and heavy regularization. In brief, Inception V3 network stacks
11 inception blocks where each block consists of convolution
filters and pooling filters with rectified linear units as activation
functions. The input of the model is a two-dimensional image
with three channels. At the end of the model, we apply a global
averaging pooling layer and add a fully connected layer of
size 2048. A dropout rate of 0.6 is used to reduce overfitting.
Transfer learning is utilized to reduce training time, with the
network pretrained on Imagenet [21]. The model is then fine-
tuned on our datasets.
B. Activation Functions
The proposed GEV activation function is implemented as
a network layer with three trainable parameters, ξ, µ, σ.
Extreme value distributions are designed explicitly for long-
tailed distributions, such as those produced when one class has
relatively few cases [10]. Extreme value theory allows us to
better model the tail of the distribution than the traditionally
used sigmoid activation. The GEV distribution cumulative
distribution function (CDF) is given by:
F (x|ξ, µ, σ) =
{






), if ξ 6= 0.
(1)
This distribution is a generalization of three extreme value
distributions. When ξ = 0, the GEV becomes the Gumbel
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Sigmoid                                       
GEV: ξ=1, µ=2, σ=2
GEV: ξ=−1, µ=2, σ=−1 
True: ξ=0.0068, µ=1.011, σ=0.
Fig. 2. Example curves of the sigmoid curve, and GEV distribution
cumulative distribution functions (CDFs). True indicates the actual curve
learned from the toy pneumonia dataset at a imbalance ratio of 1:50.
distribution, when ξ > 0, the GEV becomes the Frechet
distribution, and when ξ < 0, the GEV becomes the Weibull
distribution.
To assess the added benefit of the proposed activation
function, we compare the proposed activation function with





Examples showing the sigmoid curve and three types of
GEV CDF are shown in Figure 2. The three parameters allow
the GEV to adapt. Small changes within the parameters can
lead to large differences in predictions. The GEV activation
function has three trainable parameters that change the shape
and scale of the curve. In traditional statistics, the GEV
parameters would be estimated using maximum likelihood
[47], which requires a full rank design matrix; however, in a
deep learning context, these parameters can be learned through
gradient descent along with the other model parameters. This
only adds an extra three parameters to be trained.
C. Datasets
1) Balanced Dataset: To evaluate our activation function we
first look at a widely used toy dataset related to our main aim.
The dataset consists of community acquired pneumonia and
normal X-ray images [48]. We begin by balancing the data to
1,583 in each class giving a ratio of 1:1. We split the data
into 800 images for training, 200 images for validation, and
583 images for testing, from each class. We then reduce the
number of pneumonia images in the training and validation
sets, with testing remaining constant. Pneumonia images were
removed to give pneumonia:normal ratios of 1:10, 1:25 and
1:50.
2) X-Ray Datasets: COVID-19 positive X-Rays were ob-
tained from the COVID-19 image data collection [13], consist-
ing of images from a variety of sources such as case notes and
publications. In the training and validation, we used images
from the Italian Society of Radiology [49] only, with images
(a) (b) (c)
Fig. 3. Examples images of (a) healthy patient, (b) COVID-19 patient,
and (c) bacterial pneumonia patient.
obtained from other sources used for testing/external valida-
tion. Healthy X-rays for training and validation were taken
from the ChestX-Ray8 [14], with testing/external validation
images taken from Kermany et al. [48] and the Shenzhen
Hospital X-Ray dataset [50].
Any images with distinguishing annotations/artifacts that
could not be cropped out or less than 256 pixels in either
height or width were removed. After this, we were left with 30
COVID-19 and 40,240 healthy images in the training dataset,
15 COVID-19 and 20,120 healthy images in the validation
dataset, and 84 COVID-19 and 1,907 images in the external
validation/testing dataset. In training and validation sets, the
normal to COVID-19 ratio is 1341:1.
We also obtained pneumonia images to assess the model
performance in distinguishing COVID-19 from healthy or
pneumonia (bacterial and viral) images. From the ChestX-
Ray8 dataset, we added 944 pneumonia images to the training
set and 472 images to the validation set. From the Kermany
et al. dataset [48], we added 4,273 images to the testing set.
Example images are presented in Figure 3.
3) CT Datasets: A private CT dataset comprising subjects
with or without COVID-19 was collected and used with all rel-
evant approval. This dataset consists of 1919 non-COVID-19
images and 30 COVID-19 images. We divided this the dataset
into 909 non-COVID-19 and 15 COVID-19 for training, 303
non-COVID-19 and 5 COVID-19 for validation, and 707 non-
COVID-19 and 10 COVID-19 for testing. The ratio of non-
COVID-19 to COVID-19 images is at 60.6:1. Example images
are shown in Figure 4. We then externally validated the trained
model on data from two publicly available datasets, using the
same exclusion criteria as for X-ray. The first dataset is taken
from the COVID-CT-Dataset [51], the second from the Italian
Society of Radiology [49]. From the COVID-CT-Dataset, we
extracted 169 non-COVID images and 100 COVID-19 images.




All experiments were performed on a Linux machine run-
ning Ubuntu 18.04, with 32GB of memory and a 12GB Titan
X graphics card. Models were developed using Keras 2.3.1
[52] with Tensorflow 2.1.0 [53] as the backend. Analysis of
the results was carried out in R [54] using the pROC [55],
reportROC [56], and PredictABEL [57] packages. Source code
is available at https://github.com/JBridgeLiverpool/GEV.
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(a) (b)
Fig. 4. Examples of (a) non-COVID-19 and (b) COVID-19 positive CT
scans.
The discriminative performance was evaluated using the
AUC, sensitivity, and specificity, with the optimum chosen
based upon Youden’s index. We assessed reclassification using
the net reclassification index (NRI). DeLong’s method [58]
was used to construct 95% confidence intervals for AUC,
and 2000 sample bootstrapping for sensitivity and specificity.
Difference in AUCs was identified using DeLong’s test [58].
Model training was conducted with 250 epochs with model
checkpoints and early stopping with a patience of 10, to
prevent overfitting. The best model was chosen based on the
validation AUC. The initial learning rate was set to 1e-4
and was reduced to two-thirds if the validation AUC did not
improve after five epochs. All hyperparameters were kept the
same for all experiments.
V. RESULTS
In this section, we will present our results from the exper-
iments that we have described above. We will compare the
proposed GEV activation function with the previously used
sigmoid activation. We begin with results in the toy healthy
vs. pnemonia dataset, to show how the ratio of imbalance
affects the results. Results on X-rays are then given for
healthy vs. COVID-19 images, then for healthy and pneumonia
vs. COVID-19. We also demonstrate the performance of the
activation function on CT images. The proposed activation
function can be combined with other long-tailed distribution
methods to improve accuracy further; to demonstrate this, we
also use class weights in the model training. GradCAMs [33]
were used to highlighted areas that the model believes more
important for the prediction where more bright yellow means
more relevant while blue means less relevant.
A. Balanced data
We began by comparing the GEV function with the sigmoid
activation in a balanced dataset of X-ray images. We then
increase the ratio of imbalance to assess at what point the
proposed activation function becomes useful. We also compare
with a popular resampling technique, namely oversampling,
which repeats cases from the smaller dataset to rebalance the
set.
When data is balanced we observe no significant differ-
ence in performance between the sigmoid activation and the
proposed GEV activation, the same is also true at a small
imbalance ratio of 1:10, with oversampling also showing no
significant difference. When the imbalance is increased to
TABLE I
RESULTS OF PNEUMONIA VS. HEALTHY WITH DIFFERENT RATIOS OF
IMBALANCE. SIGMOID INDICATES NO BALANCING METHOD USED, OS
USES OVERSAMPLING WITH THE SIGMOID ACTIVATION, GEV INDICATES
THE PROPOSED GEV ACTIVATION. VALUES FOR OS SIGMOID WITH
BALANCED DATA ARE OMITTED AS NO RESAMPLING STRATEGY IS
NEEDED HERE.
Ratio
P:N Method AUC Sens Spec
























































1:25, the GEV provides a statistically significant improvement
in AUC and sensitivity over the sigmoid activation; however,
using oversampling also improves sensitivity. There is a non-
significant increase in performance when using GEV rather
than oversampling. At a ratio of 1:50, GEV again provides
a significant increase in AUC and sensitivity; however, over-
sampling overfits and classifies almost all images as negative.
Here, we see that resampling strategies may lead to overfitting,
even at relatively low levels of imbalance.
Results are displayed in Table I, with the learned GEV
activation function for the ratio 1:50 displayed in Figure 2
compared to the sigmoid function and two other possible GEV
curves.
B. COVID-19 vs. Healthy
In the binary classification between COVID-19 and healthy,
the proposed method achieves an AUC of 0.820 (95% con-
fidence interval [CI]: 0.770, 0.870), 0.798 (95% CI: 0.712,
884) sensitivity, and 0.778 (95% CI: 0.759, 0.796) specificity
in the testing dataset. The sigmoid activation attained an
AUC of 0.750 (95% CI: 0.690, 0.809), sensitivity of 0.488
(95% CI: 0.381, 0.595), and specificity of 0.932 (95% CI:
0.921, 0.944). Results are presented in Table II, with the
ROC presented in Figure 5. DeLong’s test for a difference in
AUC gave a p-value <0.05, indicating that our AUC value
is significantly higher than that of using sigmoid function
at the 95% confidence level. The NRI between the model
using the sigmoid activation and the proposed GEV activation
is 0.2845 (95% CI: 0.1664, 0.4026), indicating a significant
improvement in the classification of GEV activation. Saliency
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TABLE II
RESULTS OF COVID-19 VS. HEALTHY X-RAY IMAGES. 95%
CONFIDENCE INTERVALS ARE GIVEN IN BRACKETS





























Fig. 5. Receiver operating characteristic curve for COVID-19 vs.
healthy X-ray images using both the traditional sigmoid activation and
the proposed GEV activation, with 95% confidence bands.
maps were produced to show which areas of the image were
considered relevant by the algorithm, shown in Figure 6.
C. COVID-19 vs. Healthy and Pneumonia
For the classification of COVID-19 versus healthy and
pneumonia, our method achieves an AUC, sensitivity, and
specificity of 0.731 (95% CI: 0.672, 0.790), 0.726 (95% CI:
0.631, 0.822), and 0.669 (95% CI: 0.657, 0.681), respec-
tively. The sigmoid activation attains an AUC, sensitivity,
and specificity of 0.752 (95% CI: 0.684, 0.819), 0.571 (95%
CI: 0.466, 0.677), and 0.886 (95% CI: 0.878, 0.894), respec-
tively. Delong’s test [58] shows a non-significant difference
in AUC (p=0.370); however, the NRI suggests a significant
improvement in classification (p<0.0001), when using the
GEV activation. Results are presented in Table III, with the
Fig. 6. CAMs of some testing images for the classification of COVID-
19 vs. healthy images. Red areas show which parts of the image the
algorithm believes to be useful in the diagnosis. The algorithm appears
to identify the correct regions of interest, concentrating on areas with
GGO and consolidation.
TABLE III
RESULTS OF COVID-19 VS. HEALTHY AND PNEUMONIA X-RAY IMAGES.
95% CONFIDENCE INTERVALS ARE GIVEN IN BRACKETS.





























Fig. 7. Receiver operating characteristic curve for COVID-19 vs. healthy
and pneumonia X-ray images using both the sigmoid activation and the
proposed GEV activation, with 95% confidence bands.
ROC curve shown in Figure 7. Figure 8 presents some example
saliency maps that highlight which parts the algorithm believes
to be useful in the diagnosis.
D. Classification Using CT
To demonstrate the generalizability of our proposed acti-
vation function, we also applied the proposed GEV activa-
tion function on computerized tomography images. Here, we
classify COVID-19 vs. other patients. The GEV activation
achieves an AUC, sensitivity, and specificity of 1.0 (95% CI:
1.0, 1.0), 1.0 (95% CI: 1.0, 1.0), and 1.0 (95% CI: 1.0, 1.0),
respectively. The sigmoid activation attains an AUC, sensitiv-
ity, and specificity of 0.6498 (95% CI: 0.444, 0.855), 0.40
(95% CI: 0.096, 0.704), and 0.908 (95% CI: 0.887, 0.929),
respectively. External validation using the datasets previously
Fig. 8. Saliency maps of some testing images for the classification of
COVID-19 vs. healthy and pneumonia X-ray images. Red areas show
which parts of the image the algorithm believes to be useful in the
diagnosis.
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TABLE IV
RESULTS OF COVID-19 VS. HEALTHY IN THE CT TESTING DATASET.
THE SIGMOID ACTIVATION CLASSIFIED ALL IMAGES AS NON-COVID,
RESULTING IN THE UNUSUAL CONFIDENCE INTERVALS GIVEN IN
BRACKETS.





























Fig. 9. Receiver operating characteristic curve for COVID-19 vs. other
CT images using both the sigmoid activation and the proposed GEV
activation.
described attained an AUC, sensitivity, and specificity of 0.675
(95% CI: 0.621, 0.730), 0.628 (95% CI: 0.561, 0.695), and
0.651 (95% CI: 0.579, 0.723), respectively, using the GEV
activation. The sigmoid activation attained 0.561 (95% CI:
0.502, 0.620), 0.0 (95% CI: 0.0, 0.0), and 1.0 (95% CI: 1.0,
1.0), for AUC, sensitivity and specificity respectively. The
sigmoid activation classified all images as non-COVID giving
perfect specificity with 0.0 specificity. DeLong’s test indicated
a significant difference in AUCs at the 95% confidence level
(p=0.002), the NRI also indicated a significant improvement
in classification. Results are shown in Table IV with the ROC
curve shown in Figure 9 and CAMs maps shown in Figure
10. The CAMs shown here identify correct regions; however
in the first and second CAMs, the left side of the image is
also identified. The lungs were not segmented, so there is a
lot of noise outside of the region of interest. This suggests
that segmenting the lung and masking all other regions before
classification may be useful.
E. Extension to Other Networks
To demonstrate that the proposed network extends to other
neural networks, we reperform the COVID-19 versus healthy
patients experiments using another pretrained neural network,
namely MobileNet. We chose MobileNet as it is specifi-
cally designed to be smaller and more deployable than other
deep neural networks. As COVID-19 diagnostic models are
deployed, more computationally efficient algorithms will be
needed to reduce the cost to healthcare services. MobileNet
uses depth-wise separable convolutions to reduce the computa-
tional complexity of the network, with only a small reduction
in accuracy. The network is designed
Fig. 10. CAMs of some testing images for the classification of COVID-
19 vs. other CT images. Red areas show which parts of the image the















Fig. 11. Receiver operating characteristic curve for COVID-19 vs. other
CT images using both the sigmoid activation and the proposed GEV
activation.
The sigmoid activation attains an AUC, sensitivity, and
specificity of 0.759 (95% CI: 0.692, 0.827), 0.679 (95% CI:
0.579, 0.778), and 0.777 (95% CI: 0.758, 0.795), respectively.
While the GEV activations attains an AUC, sensitivity, and
specificity of 0.888 (95% CI: 0.838, 0.937), 0.774 (95% CI:
0.684, 0.863), and 0.918 (95% CI: 0.905, 0.930), respectively.
DeLong’s method indicated a non-zero difference in AUC (p
<0.0001) and the NRI shows a significant improvement in
classification (p <0.0001). The ROC curve is shown in Figure
11.
VI. DISCUSSION
In this work, we have proposed a novel activation function
inspired by extreme value theory and studied its significance
for the diagnosis of COVID-19. The proposed GEV activation
is better suited to highly unbalanced data than the commonly
used sigmoid activation. Experiments conducted using both X-
ray and CT imaging to diagnose COVID-19 have shown that
the GEV activation function significantly increases sensitivity
compared to sigmoid.
On a balanced dataset, we found no significant difference
between the GEV activation and the sigmoid activation. As
the ratio of imbalance between the classes increased, we
found that the GEV activation provided improved sensitivity,
accounting for the relatively small number of positive images.
Compared to oversampling, when the ratio of imbalance was
low, there was no signifcant difference to the GEV activation.
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However, at a ratio of 1:50, oversampling lead to overfitting,
with worse performance that using the sigmoid activation
alone. This highlights a common criticism of resampling
procedures.
In the diagnosis of COVID-19, hospitals are beginning to
use a chest X-ray before CT, as an X-ray is much faster,
cheaper, and the machine is much easier to clean than the
CT scanner after use. Any negative patients are sent for a CT
to confirm the negative diagnosis; hence, it is vital to improve
the sensitivity of X-ray algorithms to reduce the number of
unnecessary CTs. It is reported that the sensitivity of X-rays
for the diagnosis is only about 0.69 in clinical settings [59]. It
is expected that automated AI diagnosis algorithms can help
to improve sensitivity.
For the COVID-19 vs. healthy experiment, the GEV activa-
tion function gave a statistically significant increase in AUC,
with a significantly improved sensitivity while maintaining
a reasonably high specificity. In the COVID-19 vs. healthy
and pneumonia experiment, the GEV activation had a non-
significant decrease in AUC with the benefit of increasing
sensitivity significantly.
In the CT experiment, the internal testing set was too small
to be meaningful (10 patients), and the model using the GEV
activation attained perfect performance, while the model using
the sigmoid activation was equivalent to random chance. In
the external validation set, the GEV model had much lower
performance; however, the model still improved significantly
over the sigmoid model, which just classified all images as
non-COVID.
We have also shown that the proposed activation function
generalizes to other networks and improves over the previously
used sigmoid activation. In this case, the proposed activation
function gave a non-significant increase in sensitivity but gave
a significant increase in specificity at the 95% confidence level.
In all experiments, while the AUC was not necessarily
improved, the sensitivity was always increased and the NRI
indicated that the classification was significantly improved
upon when using the GEV activation.
COVID-19 is a new challenge, as yet there is no consen-
sus on performance requirements for any diagnostic models.
From our experience, it is believed high sensitivity with a
reasonably good specificity would be a preferred option; any
false negatives will leave COVID-19 undiagnosed, increasing
the risk of spreading this highly infectious disease, while
any false negatives may only lead to unnecessary further
investigations including CT. Our activation function leads to
preferable models over the sigmoid function.
We are cautious to compare out quantitative results with
previous work, as summarized in Shi et al [7]. Although the
previous models have shown the potential of AI, they often
only use a relatively small testing dataset. For instance, the
total number of positive cases is between 45 and 100 for the
X-ray work [16], [17], [22]. The need for large amounts of
training data has led to very few COVID-19 images being used
in the testing set. This makes it challenging to determine the
model performance and generalizability fully. The proposed
GEV activation requires fewer COVID-19 images in the train-
ing dataset, meaning we can use more images in the testing
set. Although we may not necessarily obtain improved results
over previously published COVID-19 diagnostic models, we
show that our approach may help to improve those methods,
particularly the sensitivity. The other reason for not comparing
our model to previous models is that we are not able to obtain
the exact same datasets for the experiments, to report the
performance. To make a fair comparison, community effort is
needed to curate a dataset for reproducible research. It is also
of great importance to standardize how results are reported and
the measures of a successful model. A systematic review by
Wynants et al. [8] identified eight studies diagnosing COVID-
19 and found that the risk of bias was high in all studies,
according to PROBAST [39]. In this work, we have strived
to follow best practices for prediction modes, as outlined by
PROBAST [39] and TRIPOD [60], and would encourage new
prediction models in AI to follow PROBAST and TRIPOD
guidelines carefully to increase the robustness of developed
models.
Similar to previous studies, the most significant limitation
of this study lies in the data used. First, relatively few images
are available in the public domain. The data that is available is
curated by several initiatives, and typically they are COVID-19
images, without matching negative controls. Currently, non-
COVID images must be found elsewhere, and these often
use different protocols, making the images slightly different
in appearance. Secondly, those that are available are often of
low quality, for example: the COVID-19 Image Collection is
extracted from published papers and reports [13]. Annotations
or captions are on many of the images and it is not always
possibly to crop these annotations out. The contrast may have
been adjusted during the publication process, and some were
downsampled, leading to a significant reduction in details. For
the healthy X-ray images used here, although we aimed to crop
annotations out of every image, with such a large dataset, we
were forced to use an automated cropping technique; this may
leave some images still with annotations. It is also possible
that some labels in the datasets used were wrong. The samples
may also not be representative of the overall population. When
we developed our CT model (unreported results), we firstly
used publicly available datasets for training; the non-COVID-
19 images came from a lung cancer screening set, and the
COVID-19 came from [13]. We found that performance was
near perfect. After further investigation, we found that the
algorithm was learning the appearance of the images and
not the features of COVID-19. This highlights the dangers
of black-box models and the need for visualization techniques
such as saliency maps. We then obtained higher quality images
for training, and those results are presented here. Third, many
datasets do not contain clinical or demographic information,
such as diagnostic test used, age, or gender; these could be
used to further imporve models. There is a lack of information
on how the image is generated from the raw data. For instance,
different window functions will produce different appearance
of the same CT. These need to be standardized if there is to
be a public dataset being made available in the future.
Although we only considered COVID-19 here, the method
can be used whenever one class significantly outweighs the
other, such as is the case in rare diseases. Future work is
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needed, both in COVID-19 and other diseases, to confirm the
benefit of the proposed activation function and to assess the
situations in which it is preferable over the sigmoid activa-
tion. In our experiments, we combined the GEV activation
with class weights; Other experiments without class weights
experienced a loss of model performance (unreported results).
This suggests that a combination of methods may be the
best strategy. The effect of other data-efficient methods also
needs to be assessed. The proposed method also needs to be
extended to multiclass problems. For COVID-19 diagnosis, the
proposed activation function needs to be tested on improved
base networks to provide improved diagnostic performance.
Although only diagnosis is considered here, CT is likely to
play an important role in the treatment and in monitoring the
progression of COVID-19. Future work is needed to consider
how AI can aid clinicians in decision making for the treatment
of COVID-19.
This work, along with previous work, has displayed the
potential of AI in the diagnosis of COVID-19, these algorithms
will be used as either standalone tools or as diagnostic aids to
existing systems, to support decision making. Any methods
deployed must first be appropriately validated in clinical
settings to obtain regulatory approval
VII. CONCLUSIONS
We propose an activation function based on the generalized
extreme value distribution. The GEV activation improves
model performance in binary classification when one class
significantly outweighs the other. The method is applied to
a COVID-19 dataset and improves upon a standard pretrained
network using the sigmoid activation. Future models using
highly unbalanced data may benefit from using the proposed
activation function. We hope these models could support better
management for COVID-19 with improved sensitivity.
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